West Announces Quarterly Dividend
Get Alerts WST Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.3%
Revenue Growth %: +2.7%
Join SI Premium – FREE
EXTON, PA -- (Marketwired) -- 07/01/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company will pay a third-quarter 2015 dividend of $0.11 per share. The dividend will be paid on August 5, 2015 to shareholders of record as of July 22, 2015.
About West
West Pharmaceutical Services is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2014 sales of $1.42 billion reflect the daily use of approximately 110 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world. www.westpharma.com
West and the diamond logo and By your side for a healthier world" are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506
Source: West Pharmaceutical Services, Inc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
- ServisFirst Bancshares, Inc. to Announce Third Quarter 2026 Financial Results October 19th
- Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share